Sandeep Laumas
Director of Finance/CFO bij INSTIL BIO, INC.
Vermogen: 146 025 $ op 31-03-2024
Actieve functies van Sandeep Laumas
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Director/Board Member | 01-09-2017 | - |
| Independent Dir/Board Member | 01-09-2017 | - | |
| UNICYCIVE THERAPEUTICS, INC. | Director/Board Member | 01-01-2018 | - |
| Independent Dir/Board Member | 01-01-2018 | - | |
| INSTIL BIO, INC. | Comptroller/Controller/Auditor | 01-02-2021 | - |
| Director of Finance/CFO | 01-02-2021 | - | |
| Corporate Officer/Principal | 01-06-2020 | 01-02-2021 | |
| Bearing Circle Capital LP | Founder | 01-08-2007 | - |
| Corporate Officer/Principal | 01-08-2007 | - | |
Globavir Biosciences, Inc.
 Globavir Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Globavir Biosciences, Inc. develops therapeutics and diagnostics for the treatment of infectious diseases. The American company was founded in 2011 by Shalabh Gupta, who has been the CEO since 2011. | Director/Board Member | 01-01-2015 | - |
Loopbaan van Sandeep Laumas
Eerdere bekende functies van Sandeep Laumas
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Director/Board Member | - | 01-04-2022 |
| 9 METERS BIOPHARMA, INC. | Director/Board Member | 30-04-2020 | 22-06-2021 |
| Chief Executive Officer | 19-02-2019 | 30-04-2020 | |
| Chairman | 01-01-2014 | 30-04-2020 | |
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Director/Board Member | 01-05-2013 | 01-08-2017 |
Agilus Diagnostics Ltd.
 Agilus Diagnostics Ltd. Medical/Nursing ServicesHealth Services SRL Ltd. engages in the provision of diagnostic services. It offers pathology and radiology testing, preventive care and clinical research, hematology and chemistry, histopathology, cytogenetic, and esoteric tests. The company was founded on July 7, 1995 and is headquartered in Gurugram, India. | Director/Board Member | 01-02-2011 | 01-01-2012 |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░░░ ░░░ ░░░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Sandeep Laumas
| Cornell University | Undergraduate Degree |
| Albany Medical College | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 12 |
| Singapore | 2 |
| India | 2 |
Operationeel
| Director/Board Member | 8 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 2 |
Sectoraal
| Health Technology | 5 |
| Finance | 3 |
| Health Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| 9 METERS BIOPHARMA, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
North Sound Capital LLC (Old)
 North Sound Capital LLC (Old) Investment ManagersFinance North Sound Capital LLC (NSC), founded by Tom McAuley, is an Old Greenwich, Connecticut-based hedge fund management firm. | Finance |
Balyasny Asset Management LP
 Balyasny Asset Management LP Investment ManagersFinance Balyasny Asset Management LP (BAM) is a multi-strategy hedge fund manager and SEC-registered investment advisor headquartered in Chicago, Illinois. The firm’s predecessor, Balyasny Capital Management LLC (BCM), was founded in 2001 by Dmitry Balyasny, Scott Schroeder and Taylor O'Malley. In 2003, BCM converted from a limited liability company to a limited partnership. Then, in January 2004, their name was changed to Balyasny Asset Management LP. They are a subsidiary of Balyasny Asset Management Holdings LP. BAM provides investment advisory services to high net-worth individuals and institutional clients through privately offered pooled investment funds. | Finance |
Parkway Holdings Ltd.
 Parkway Holdings Ltd. Hospital/Nursing ManagementHealth Services Parkway Holdings ltd. provides healthcare services. Its services include imaging, laboratory, primary care, parkway centers, and clinical research services. The company headquartered in Singapore. | Health Services |
Agilus Diagnostics Ltd.
Agilus Diagnostics Ltd. Medical/Nursing ServicesHealth Services SRL Ltd. engages in the provision of diagnostic services. It offers pathology and radiology testing, preventive care and clinical research, hematology and chemistry, histopathology, cytogenetic, and esoteric tests. The company was founded on July 7, 1995 and is headquartered in Gurugram, India. | Health Services |
| Bearing Circle Capital LP | |
Globavir Biosciences, Inc.
Globavir Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Globavir Biosciences, Inc. develops therapeutics and diagnostics for the treatment of infectious diseases. The American company was founded in 2011 by Shalabh Gupta, who has been the CEO since 2011. | Commercial Services |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Technology Services |
| Unicycive Therapeutics, Inc. | |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
- Beurs
- Insiders
- Sandeep Laumas
- Ervaring
